Medication info
Pimasab Tablets 60/2.5 Milligrams

Pimasab Tablets 60/2.5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Ilseong IS Co., Ltd.
Appearance
Yellow, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300112 · Approved 2023.01.06 · Insurance code 655404600

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan potassium monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). It is recommended to adjust the dose of fimasartan before administering this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Ilseong IS Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan potassium monotherapy

  • Essential hypertension
View approved original text

This medication is recommended for patients with essential hypertension whose blood pressure is not adequately controlled with Pimasartan Potassium monotherapy. It helps to appropriately lower and manage blood pressure, thus effectively improving management of essential hypertension.

How to take

Adult dose

Adults The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). It is recommended to adjust the dose of fimasartan before administering this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication should not be used during pregnancy, especially during the second and third trimesters. It can cause serious harm to the fetus and newborn, so if pregnancy is confirmed, the medication should be discontinued immediately. Patients with allergies to the active ingredient or related components, those who are pregnant or breastfeeding, patients receiving renal dialysis, patients with severely impaired liver function, patients with biliary obstruction, and patients with certain kidney diseases or diabetic nephropathy should not take this medication. Additionally, patients with certain genetic conditions such as lactose intolerance should also avoid this medication. Patients with low blood volume or reduced sodium levels, patients with impaired kidney function, patients with specific heart diseases, and the elderly should use this medication with caution, and symptoms of hypotension should be monitored during initiation or dose increases. This medication may cause side effects, including dizziness, headache, edema, urination disorders, insomnia, and facial flushing. Moreover, rare but serious side effects such as worsening kidney function, hypotension, hyperkalemia, and liver dysfunction may occur, so if unusual symptoms arise, consult a doctor immediately. There is a risk of hypotension or electrolyte imbalance when taking this medication, so regularly checking blood pressure and electrolyte levels is essential. This medication may interact with other antihypertensive agents, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so inform your doctor or pharmacist about any other medications you are taking. Women who are pregnant or planning to become pregnant should consult a doctor before taking this medication, and those who are breastfeeding should either avoid using this medication or discontinue breastfeeding. Safety and efficacy in children and adolescents under 18 years old have not been established, so use is not recommended. Elderly patients may also be more sensitive to this medication, so caution is needed. Patients with severely impaired liver function should not use this medication. In case of overdose, symptoms like hypotension and arrhythmias may occur, and appropriate medical treatment should be sought immediately. This medication should be kept out of reach of children and should not be transferred to another container to maintain quality.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disorders
  • insomnia
  • flushing
  • syncope
  • sedation
Show 153 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • deterioration of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute kidney failure
  • chronic kidney failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • back pain
  • edema
  • limb pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fractures
  • myalgia
  • pharyngitis
  • upper respiratory tract infection
  • sputum
  • rhinitis
  • epistaxis
  • bronchitis
  • paresthesia
  • numbness
  • tremors
  • hypertonicity
  • anxiety
  • memory impairment
  • appetite loss
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional gastrointestinal disorder
  • gastroenteritis
  • frequent urination
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • cerebral infarction
  • shingles
  • visual disturbances
  • tachycardia
  • hypertension
  • fatty liver
  • skin erythema
  • maculopapular rash
  • weakness
  • lethargy
  • pain
  • weight gain/loss
  • hypotension
  • vasculitis
  • increased tension
  • sensory impairment
  • peripheral neuropathy
  • taste disturbances
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • thrombocytopenia
  • insomnia
  • mood changes
  • dyspnea
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; therefore, it should be stored in a container that does not allow light in. Moreover, it is best to maintain a storage temperature between 1 and 30 degrees Celsius to safely preserve its effectiveness.

Appearance and packaging

Appearance

Yellow, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.